United States · 
Who invested in Rapport Therapeutics?
Rapport Therapeutics's investors include Fidelity, ARCH Venture Partners, Perceptive Advisors and Cormorant Asset Management.
United States · Funded startup
Who invested in Rapport Therapeutics
Funding summaryUpdated 26 Oct 2026
$250Mraised across 1 round since 2025, from 1 source
- Latest round
- Round, $250MSept 2025
- Investors
- 4
The rounds
- Sept 2025
Founders and team
From Rapport Therapeutics's own website: 4 on the team.
- Abraham N. CeesayChief Executive Officer
- Cheryl GaultChief Operating Officer
- Kathy WilkinsonChief People Officer
- Troy IgnelziChief Financial Officer
Everyone who backed them
FidelityVC firm1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Rapport Therapeutics
How much has Rapport Therapeutics raised?
Rapport Therapeutics has raised $250M across 1 round since 2025.
When did Rapport Therapeutics last raise?
Rapport Therapeutics's most recent round was an Undisclosed round of $250M in Sept 2025.
What was Rapport Therapeutics's biggest round?
Its most recent round, $250M in Sept 2025, is also its largest on record.
Who backed Rapport Therapeutics first?
Rapport Therapeutics's first round on record, in Sept 2025, was backed by Fidelity, ARCH Venture Partners and Perceptive Advisors and 1 others.
What stage is Rapport Therapeutics at?
Rapport Therapeutics's latest named round is an Undisclosed round, in Sept 2025.
Where is Rapport Therapeutics based?
Rapport Therapeutics is based in the United States.
Companies like Rapport Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.